JACOBS LEVY EQUITY MANAGEMENT, INC - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 65 filers reported holding ENDOCYTE INC in Q3 2017. The put-call ratio across all filers is 2.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of ENDOCYTE INC
ValueSharesWeighting
Q2 2018$266,000
+52.0%
19,3000.0%0.00%
+33.3%
Q1 2018$175,000
-61.6%
19,300
-81.9%
0.00%
-62.5%
Q4 2017$456,000
+1012.2%
106,641
+267.2%
0.01%
+700.0%
Q3 2017$41,000
-80.8%
29,041
-79.5%
0.00%
-80.0%
Q2 2017$213,000
+187.8%
141,772
+395.2%
0.01%
+400.0%
Q1 2017$74,000
-62.1%
28,627
-62.5%
0.00%
-75.0%
Q4 2016$195,000
+26.6%
76,374
+53.5%
0.00%
+33.3%
Q3 2016$154,000
-29.0%
49,754
-26.3%
0.00%
-25.0%
Q2 2016$217,000
-5.2%
67,493
+85.4%
0.00%0.0%
Q4 2014$229,00036,4000.00%
Other shareholders
ENDOCYTE INC shareholders Q3 2017
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
RMB Capital Management, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders